Associations of perceived neighborhood factors and Alzheimer’s disease polygenic score with cognition: Evidence from the Health and Retirement Study
PLOS One · 2025
DOI: 10.1371/journal.pone.0336403 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Erin B Ware und 7 weiteren Autor:innen. Beteiligte Einrichtung: Survey Research Center, Institute for Social Research Center, University of Michigan, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognition, Multifactorial Inheritance, Cognitive Dysfunction. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Background
We examined the relationships between neighborhood characteristics, cumulative genetic risk for Alzheimer’s disease (polygenic scores for Alzheimer’s disease), and cognitive function using data from the Health and Retirement Study (2008–2020, age > 50).
Methods
Baseline perceived neighborhood characteristics were combined into a subjective neighborhood disadvantage index. Cognitive function was assessed at baseline and measured biennially over a 10-year follow-up period. Analyses were stratified by genetic ancestry. Cox proportional hazard models analyzed associations between neighborhood characteristics, Alzheimer’s disease polygenic scores, and their interactions on cognitive impairment.
Results
In the European ancestries sample, a one standard deviation higher score on the subjective neighborhood disadvantage index was associated with a higher hazard of any cognitive impairment (HR:1.09; CI:1.03–1.15), cognitive impairment without dementia (HR:1.08; CI:1.03–1.14), and dementia (HR:1.13; CI:1.03–1.24). Similarly, a one standard deviation increase in Alzheimer’s disease polygenic score was associated with a higher risk of cognitive impairment (HR:1.10; CI:1.05–1.16) and cognitive impairment without dementia (HR:1.10; CI:1.05–1.16) but not dementia (HR:1.05; CI:0.96–1.16). No significant interactions were found. Evidence in African ancestries were directionally similar but imprecise and inconclusive due to limited precision and cross-ancestry polygenic score transferability. Subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score were independently associated with incident cognitive impairment.
Conclusions
Preventing dementia by addressing modifiable risk factors is essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Survey Research Center, Institute for Social Research Center, University of Michigan, Ann Arbor, Michigan, United States of America.
- Population Studies Center, Institute for Social Research Center, University of Michigan, Ann Arbor, Michigan, United States of America.
- School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America.
ORCID-Profile: Erin B Ware, Peiyao Zhu, Kelly M Bakulski
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Ware, E. B., Zhu, P., Noppert, G., Fu, M., Benbow, M., Kobayashi, L. C., Ryan, L. H., & Bakulski, K. M. (2025). Associations of perceived neighborhood factors and Alzheimer’s disease polygenic score with cognition: Evidence from the Health and Retirement Study. PLOS One. https://doi.org/10.1371/journal.pone.0336403
Vancouver
Ware EB, Zhu P, Noppert G, Fu M, Benbow M, Kobayashi LC, et al. Associations of perceived neighborhood factors and Alzheimer’s disease polygenic score with cognition: Evidence from the Health and Retirement Study. PLOS One. 2025. doi:10.1371/journal.pone.0336403
BibTeX
@article{Ware2025,
author = {Ware, Erin B and Zhu, Peiyao and Noppert, Grace and Fu, Mingzhou and Benbow, Mikayla and Kobayashi, Lindsay C and Ryan, Lindsay H and Bakulski, Kelly M},
title = {Associations of perceived neighborhood factors and Alzheimer’s disease polygenic score with cognition: Evidence from the Health and Retirement Study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336403}
}
EUVIMED